甲基叶酸与抗抑郁药的联合治疗对患有抑郁症的患者的影响
Afifa Siddique1, Muhammad Masood Khokhar2, Akbar Waheed3
1Department of Pharmacology, Islamic International Medical College (IIMC), Riphah International University, Rawalpindi, Pakistan. afifa.siddique@riphah.edu.pk.
BMC pharmacology & toxicology
|January 23, 2025
概括
在抗抑郁药物治疗中添加低剂量的甲基叶酸盐显著改善了抑郁症症状,远远超过单独使用抗抑郁药. 这种组合疗法在治疗抑郁障碍方面似乎是安全有效的.
科学领域:
- 精神病学和临床心理学
- 药理学和治疗学 药理学和治疗学
背景情况:
- 抑郁症是一种普遍存在的心理健康状况,需要有效的治疗策略.
- 正在探索辅助疗法,以提高抗抑郁药的有效性和患者的治疗结果.
研究的目的:
- 在被诊断患有抑郁症的患者中,比较联合治疗 (抗抑郁药 + 甲基叶酸盐) 与抗抑郁药单一治疗的有效性.
- 评估对抑郁症症状改善,缓解率和症状出现时间的影响.
主要方法:
- 一个开放的临床试验,涉及44名患有抑郁症的患者.
- 参与者接受了标准的抗抑郁药疗法,实验组也每天接受800微克甲基叶酸盐,持续4周.
- 在基线,第14天和第28天使用患者健康问卷-9 (PHQ-9) 评估抑郁症症状.
主要成果:
- 组合治疗组在28日前显示,抑郁症症状有40.33%的改善,明显大于单一治疗组的26.43%的改善 (p < 0.05).
- 在症状改善的时间延迟 (14日) 或缓解率 (28日) 中没有观察到统计学上显著的差异.
- 组合疗法一般耐受良好,只有少数患者报告的不眠症和易怒等轻微不良事件.
结论:
- 与抗抑郁药物和低剂量甲基叶酸盐的联合治疗表明,与抗抑郁药单一治疗相比,在改善抑郁症状方面具有更强的疗效.
- 这种治疗方法是治疗抑郁症的潜在安全和有效选择.
- 进一步的研究可能会探索最佳剂量和长期影响.
相关概念视频
01:23Antidepressant Drugs: MAOIs and Other Agents
185
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
185
01:27Combined Effects of Drugs: Synergism
3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.7K
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
294
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
294
01:25Antidepressant Drugs: Overview
353
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
353
01:28Drug Therapy
37
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
37
01:30Electroconvulsive Therapy
22
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
22